Ladenburg Thalmann analyst Wangzhi Li lowered the price target on Krystal Biotech (NASDAQ: KRYS) to $50.00 (from $53.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE